Healthcare Committee Session on Pharmacovigilance
On February 15, the AmCham Healthcare Committee gathered for a technical meeting on regulations concerning the pharmacovigilance of medicinal products and best practices on the management of systems which ensure that information concerning all suspected adverse reactions is collected and evaluated. Discussions have also touched upon aspects concerning the elaboration and submission of periodic safety update reports (PSUR) and other relevant documentation.
Should you have questions regarding this meeting, please contact Elena Popic, Committee Coordinator at elenapopic@amcham.md or 22 21 - 781
Members Spotlight
Current number of members 180
Latest Advocacy on the Go